OBJECTIVE :
@EN The purpose of this study was to investigate clinical characteristics of adenocarcinoma of the uterine cervix.
@ES STUDY METHODS :
@EN This study is a retrospective analysis of 103 patients with adenocarcinoma of cervix treated at the Kosin Medical Center from 1984 to 1993.
@ES RESULTS :
@EN The distribution by stage of disease included FIGO stage I, 51(49.6%); stage II, 32(31%); stageⅡ, 32(31%); stageⅢ, 17(16.5%); stage Ⅳ, 3(2.9%). The 2-year survival results for patients with stage I was 93.5%; stage II was 72.4%; stage
Ⅲwas
46.2%
and stage Ⅳ was none survived. And 4-year survival results : 83.3%, 59.1% and 33.3% in stage I,Ⅱ and Ⅲ, respectively. The 4-year survival rate varied significantly according to tumor size and lmph node metastasis status-below 2cm 84.2%,
2cm∼4cm
75%,
above 4cm 0% : (stage IO); negative node 91.3%, positive node 40% (stage I). The results of recurrent rate according to clinical stage was 11.8%, 25.8% 84.6% and 100% in stageⅠ, Ⅱ, Ⅲ and Ⅳ, respectively.
@ES COCLUSION :
@EN Treatment strategies should be based on the stage of disease, of disease, tumor size, lymph node metastasis status and recurrent.
|